Sangui BioTech, Inc. was incorporated in Delaware on August 2, 1996, and began operations in October 1996. In August 1997 a publicly held company, Citadel Investment System, Inc., a Colorado corporation (Citadel), acquired one hundred percent (100%) of the outstanding common shares of Sangui BioTech, Inc.; as a result, Sangui BioTech, Inc. became a wholly owned subsidiary of Citadel. Thereafter, Citadel changed its name to Sangui BioTech International, Inc. (the "Company" or "SGBI"). Until the end of fiscal year 2001/2002, SGBI's business operations were conducted through four wholly owned subsidiaries: Sangui BioTech, Inc., SanguiBioTech AG, GlukoMediTech AG, and...
To see the headquarters in Google Street View &trade, drag this yellow guy: 
over to the red pointer: 
